Annual Accounts Payable
$2.52 M
-$2.22 M-46.87%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual accounts payable is $2.52 million, with the most recent change of -$2.22 million (-46.87%) on December 31, 2023.
- During the last 3 years, ALGS annual accounts payable has fallen by -$796.00 thousand (-24.03%).
- ALGS annual accounts payable is now -46.87% below its all-time high of $4.74 million, reached on December 31, 2022.
Performance
ALGS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.74 M
-$4.08 M-59.82%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly accounts payable is $2.74 million, with the most recent change of -$4.08 million (-59.82%) on September 30, 2024.
- Over the past year, ALGS quarterly accounts payable has increased by +$223.00 thousand (+8.86%).
- ALGS quarterly accounts payable is now -64.33% below its all-time high of $7.68 million, reached on September 30, 2020.
Performance
ALGS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ALGS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.9% | +8.9% |
| 3 y3 years | -24.0% | -2.9% |
| 5 y5 years | -15.4% | -2.9% |
ALGS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | at low | -59.8% | +8.9% |
| 5 y | 5-year | -46.9% | at low | -64.3% | +72.0% |
| alltime | all time | -46.9% | at low | -64.3% | +72.0% |
Aligos Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.74 M(-59.8%) |
| Jun 2024 | - | $6.82 M(+139.9%) |
| Mar 2024 | - | $2.84 M(+12.9%) |
| Dec 2023 | $2.52 M(-46.9%) | $2.52 M(-14.4%) |
| Sep 2023 | - | $2.94 M(-9.3%) |
| Jun 2023 | - | $3.24 M(+14.8%) |
| Mar 2023 | - | $2.82 M(-40.4%) |
| Dec 2022 | $4.74 M | $4.74 M(+61.6%) |
| Sep 2022 | - | $2.93 M(+6.1%) |
| Jun 2022 | - | $2.76 M(-26.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.75 M(+24.5%) |
| Dec 2021 | $3.02 M(-9.0%) | $3.02 M(+15.9%) |
| Sep 2021 | - | $2.60 M(+63.3%) |
| Jun 2021 | - | $1.59 M(-43.3%) |
| Mar 2021 | - | $2.81 M(-15.2%) |
| Dec 2020 | $3.31 M(-12.1%) | $3.31 M(-56.9%) |
| Sep 2020 | - | $7.68 M(+133.1%) |
| Jun 2020 | - | $3.30 M(-12.5%) |
| Dec 2019 | $3.77 M(+26.5%) | $3.77 M |
| Dec 2018 | $2.98 M | - |
FAQ
- What is Aligos Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aligos Therapeutics?
- What is Aligos Therapeutics annual accounts payable year-on-year change?
- What is Aligos Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly accounts payable year-on-year change?
What is Aligos Therapeutics annual accounts payable?
The current annual accounts payable of ALGS is $2.52 M
What is the all time high annual accounts payable for Aligos Therapeutics?
Aligos Therapeutics all-time high annual accounts payable is $4.74 M
What is Aligos Therapeutics annual accounts payable year-on-year change?
Over the past year, ALGS annual accounts payable has changed by -$2.22 M (-46.87%)
What is Aligos Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ALGS is $2.74 M
What is the all time high quarterly accounts payable for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly accounts payable is $7.68 M
What is Aligos Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ALGS quarterly accounts payable has changed by +$223.00 K (+8.86%)